We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ADX.MC

Price
1.52
Stock movement up
+0.02 (1.20%)
Company name
Audax Renovables S.A.
Exchange
(MC
,
Currency
EUR
)
Sector
Utilities >
Utilities - Renewable
Market cap
686.26M
Ent value
1.53B
Price/Sales
0.35
Price/Book
3.12
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
12.62
Forward P/E
10.13
PEG
-
EPS growth
26.47%
1 year return
-20.75%
3 year return
10.23%
5 year return
-2.10%
10 year return
14.00%
Last updated: 2025-08-27

DIVIDENDS

ADX.MC does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E12.62
Price to OCF63.65
Price to FCF63.65
Price to EBITDA21.93
EV to EBITDA48.82

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales0.35
Price to Book3.12
EV to Sales0.78

FINANCIALS

Per share

Loading...
Per share data
Current share count451.49M
EPS (TTM)0.12
FCF per share (TTM)0.02

Income statement

Loading...
Income statement data
Revenue (TTM)1.96B
Gross profit (TTM)262.57M
Operating income (TTM)116.83M
Net income (TTM)54.40M
EPS (TTM)0.12
EPS (1y forward)0.15

Margins

Loading...
Margins data
Gross margin (TTM)13.41%
Operating margin (TTM)5.97%
Profit margin (TTM)2.78%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash205.16M
Net receivables207.88M
Total current assets660.68M
Goodwill138.01M
Intangible assets194.84M
Property, plant and equipment0.00
Total assets1.27B
Accounts payable183.28M
Short/Current long term debt595.53M
Total current liabilities445.72M
Total liabilities1.05B
Shareholder's equity219.93M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)10.78M
Capital expenditures (TTM)0.00
Free cash flow (TTM)10.78M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity24.73%
Return on Assets4.30%
Return on Invested Capital18.66%
Cash Return on Invested Capital3.70%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.51
Daily high1.52
Daily low1.50
Daily Volume206K
All-time high9.72
1y analyst estimate2.40
Beta1.08
EPS (TTM)0.12
Dividend per share-
Ex-div date10 Jul 2025
Next earnings date30 Sep 2025

Downside potential

Loading...
Downside potential data
ADX.MCS&P500
Current price drop from All-time high-84.36%-3.04%
Highest price drop-97.22%-56.47%
Date of highest drop25 Apr 20139 Mar 2009
Avg drop from high-79.92%-11.04%
Avg time to new high66 days12 days
Max time to new high4579 days1805 days
COMPANY DETAILS
ADX.MC (Audax Renovables S.A.) company logo
Marketcap
686.26M
Marketcap category
Small-cap
Description
Audax Renovables, S.A. engages in the generation and supplying of renewable electricity and gas in Spain, Portugal, Italy, Poland, Germany, Netherlands, France, Panama, and Hungary. The company has a portfolio of wind and photovoltaic farms with a capacity of 2,331.69 megawatts. Audax Renovables, S.A. was incorporated in 2000 and is based in Badalona, Spain. Audax Renovables, S.A is a subsidiary of Electrica Nuriel, S.L.
Employees
800
Investor relations
-
CEO
Country
Spain
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
The cider brand has added a high-contrast NaviLens QR code to its cans.
September 9, 2025
BioReference health, JPMorgan Chase and an Italian fashion retailer are making the job cuts amid market uncertainty
September 9, 2025
Temenos also the winner for Bank Deposit Transformation with Credem and listed in the 2025 IDC FinTech Rankings Top 25GRAND-LANCY, Switzerland, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Temenos (SIX: TEMN), ...
September 9, 2025
The Management Board of Artea Bankas has approved changes to the management and organizational structure. The Management Board has received a notice from board member Mindaugas Rudys regarding his res...
September 9, 2025
Novartis agreed to buy Tourmaline Bio in a roughly $1.4 billion-dollar deal that boosts its cardiovascular drug pipeline with access to the targeted therapy drug pacibekitug. The Swiss pharmaceuti...
September 9, 2025
Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Tourmali...
September 9, 2025